Latest News

Filters close
Released: 22-Sep-2022 10:50 AM EDT
Press Registration Now Open for ACR Convergence 2022
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) is providing complimentary registration to journalists wishing to write about studies presented at ACR Convergence 2022, the ACR’s annual meeting taking place Nov. 10 – 14.

Released: 20-Sep-2022 10:35 AM EDT
Rheumatology Leaders & Patient Advocates Convene on Capitol Hill to Advocate for Legislation to Improve Access to Care
American College of Rheumatology (ACR)

Physicians & health professionals from the American College of Rheumatology (ACR) along with rheumatology patients gathered on Capitol Hill this week for the annual Advocates for Arthritis event to urge lawmakers to take action on a range of policy issues affecting patient access to care.

Released: 14-Sep-2022 9:15 AM EDT
Updated Guideline Introduces Recommendations for Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) released a summary of its updated guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. New osteoporosis medications and new literature have become available since the last ACR treatment guideline was published in 2017.

Released: 8-Sep-2022 12:20 PM EDT
American College of Rheumatology Comments on 2023 Medicare Physician Fee Schedule & Quality Payment Program Rules
American College of Rheumatology (ACR)

In comments submitted to the Centers for Medicare and Medicaid Services (CMS) in response to the CY 2023 Medicare Physician Fee Schedule and Quality Payment Program proposed rule, the ACR applauded proposals that would provide more flexibility and improve care coordination.

Released: 15-Aug-2022 10:10 AM EDT
American College of Rheumatology Applauds Key Drug Pricing Reforms in Inflation Reduction Act
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) today applauded the passage of key drug pricing reforms in the Inflation Reduction Act that will improve rheumatology patients’ access to needed drug therapies and treatments.

Released: 3-Aug-2022 10:25 AM EDT
New Guideline Introduces Recommendations for Vaccinations in Patients with Rheumatic and Musculoskeletal Diseases
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) released a summary of its new treatment guideline for Vaccinations in Patients with Rheumatic and Musculoskeletal Diseases (RMDs). The effectiveness and safety of vaccines may differ in rheumatology patients as compared to the general population.

Released: 28-Jul-2022 3:40 PM EDT
ACR Statement on Access to Reproductive Healthcare
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) is deeply concerned about the U.S. Supreme Court’s Dobbs v. Jackson ruling because it negatively impacts the practice of rheumatology.

Released: 25-May-2022 11:45 AM EDT
ACR Urges the FTC to Examine the Impact of Pharmacy Benefit Managers on Prescription Drug Costs
American College of Rheumatology (ACR)

In comments submitted to the Federal Trade Commission (FTC), the American College of Rheumatology (ACR) urged the agency to address Pharmacy Benefit Manager (PBM) business practices that drive up costs and reduce access for the 54 million Americans living with rheumatic disease.

Released: 24-Mar-2022 4:30 PM EDT
American College of Rheumatology Honored with Sixth Consecutive Top Atlanta Workplace Designation
American College of Rheumatology (ACR)

The Atlanta Journal-Constitution (AJC) recognized the American College of Rheumatology (ACR) as one of Atlanta's top workplaces for the sixth year in a row. Only 87 small businesses and 175 organizations total received the recognition, and the ACR ranked 28th in the small business category.

Released: 8-Mar-2022 2:15 PM EST
New Kawasaki Disease Guideline Released by American College of Rheumatology and Vasculitis Foundation
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), released a new guideline for the management of Kawasaki disease that addresses diagnostic issues relating to the disease, the treatment of high-risk patients, & the management of convalescent patients.

Released: 3-Mar-2022 9:30 AM EST
The American College of Rheumatology Releases Two Updated Guidelines for Treatment of Juvenile Idiopathic Arthritis
American College of Rheumatology (ACR)

The ACR released two updated guideline papers for the treatment and management of Juvenile Idiopathic Arthritis (JIA). These two guidelines are companions to previously updated JIA guidelines released in 2019 covering the treatment of polyarthritis, sacroiliitis, uveitis and enthesitis.

Released: 28-Feb-2022 1:15 PM EST
Updated Guideline Introduces New Recommendations for Use of Medications Around Total Hip and Knee Replacement
American College of Rheumatology (ACR)

The ACR and the AAHKS released a summary of their updated guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

Released: 23-Feb-2022 12:15 PM EST
New American College of Rheumatology Initiatives Aim to Close the Gap on Racial Disparities in Lupus Clinical Trials
American College of Rheumatology (ACR)

The ACR is launching new initiatives to reduce racial disparities in lupus clinical trials: Training to Increase Minority Enrollment in Lupus Clinical Trials with CommunitY Engagement (TIMELY) and new Continuing Medical Education (CME) for dermatologists and nephrologists.

Released: 11-Jan-2022 12:55 PM EST
Complimentary Press Registration Available for the 2022 Winter Rheumatology Symposium
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) welcomes members of the press to write about rheumatology research presented at the Winter Rheumatology Symposium in Snowmass Village, CO on January 22 -28, 2022.

Released: 20-Dec-2021 12:00 PM EST
2021 Specialty Match Day Results Show Need to Increase Interest in Pediatric Rheumatology Fellowships
American College of Rheumatology (ACR)

The American College of Rheumatology is pleased to welcome an impressive pool of applicants to the field of rheumatology as part of the annual National Residents Matching Program (NRMP). While adult programs filled about 100 percent of their available slots, the pediatric programs only filled 69 percent, signaling a need to increase interest in pediatric rheumatology.

Released: 2-Nov-2021 4:30 PM EDT
Study Observes Worse COVID-19 Vaccine Response in Patients Taking Glucocorticoids or B-Cell Therapies
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with chronic inflammatory diseases, such as rheumatoid arthritis (RA), who take immunosuppressive therapy appear to have an impaired immunity response to SARS-CoV-2, the coronavirus that causes COVID-19, vaccines. Patients currently on glucocorticoids or B-cell depleting therapy appear to have an even more severely impeded vaccine response.

Released: 2-Nov-2021 4:20 PM EDT
Study Finds TNF Inhibitor More Effective with Regular Serum Assessment to Adjust Dose
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that proactive therapeutic drug monitoring, a newer treatment strategy where a patient’s drug serum levels are regularly assessed to adjust the dose and intervals, controlled disease more effectively than standard therapy with infliximab, a tumor necrosis factor (TNF) inhibitor.

Released: 2-Nov-2021 4:15 PM EDT
New Artificial Neural Network Detects Radiographic Sacroiliitis with Accuracy
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that an innovative new artificial neural network can detect radiographic sacroiliitis in patients with suspected axial spondyloarthritis, a progressive disease that is more common in young adults.

Released: 2-Nov-2021 4:05 PM EDT
Study Finds Statins Lower CVD and Mortality in People with RA, Only Modestly Increase Diabetes Risk
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that statins are associated with reduced rates of cardiovascular disease (CVD) and mortality in people with rheumatoid arthritis, but only modestly increase risk of type-2 diabetes, suggesting that statins’ benefits outweigh the risks in these patients.

Released: 2-Nov-2021 3:45 PM EDT
Study Finds Treat-to-Target ULT Strategy Manages Gout Effectively and Safely with No Cardiovascular Toxicity
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that allopurinol and febuxostat may effectively lower urate levels when used in a treat-to-target approach. Importantly, both urate-lowering therapies were very effective with 90% of patients reaching target urate levels. Additionally, both appeared safe, with no evidence of increased cardiovascular toxicity.

Released: 2-Nov-2021 2:40 PM EDT
Study Finds Disparities in RA Disease Activity and Physical Function Across Racial and Ethnic Groups
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that racial and ethnic disparities for disease activity persist in people with rheumatoid arthritis. Black and Hispanic patients often had higher disease activity and lower self-reported functional status when compared to white patients.

Released: 2-Nov-2021 2:35 PM EDT
Infection Rates in Psoriatic Arthritis Patients on Biologics Have Decreased, According to National Data
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows significant decreases in infections among people with psoriatic arthritis over the years 2012-2017.

Released: 2-Nov-2021 2:25 PM EDT
Study Finds Systemic Autoimmune Disease Patients Fare Well After Transplants, Making Surgery a Viable Treatment Option for End-Stage Lung Disease
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with systemic autoimmune diseases do as well after lung or heart-lung transplants as those without any systemic causes of end-stage lung disease.

Released: 2-Nov-2021 2:05 PM EDT
Early Combined Treatment with Biologic and Conventional DMARDs Could be Effective for Polyarticular Juvenile Arthritis
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that patients started on early, aggressive treatment with a combination of biologic and conventional disease modifying antirheumatic drugs (DMARDs) achieved clinically inactive disease in children with polyarticular juvenile idiopathic arthritis (JIA) more frequently compared to other treatment plans 24 months after starting treatment.

Released: 2-Nov-2021 2:00 PM EDT
Fetal Heart Rate Monitoring Can Help Manage High- Risk Pregnancies
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that heart rate monitoring is a feasible, accurate tool to check for heart rhythm abnormalities in the fetuses of pregnant women with anti-Ro/SSA antibodies.

Released: 2-Nov-2021 1:20 PM EDT
Fear of Side Effects, Including Rheumatic Disease Flares, Driving COVID-19 Vaccine Hesitancy Among Some Patients
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that in Alabama, one in 10 racial or ethnic minority patients with a rheumatic disease in a large rheumatology clinic said they were unlikely to get vaccinated against COVID-19.

   
Released: 2-Nov-2021 12:40 PM EDT
Study Finds Racial Gaps in Renal Complications Persist for Children with Lupus
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that while hospitalized children with juvenile lupus have fewer adverse kidney outcomes overall, significant racial gaps for developing these complications persist and do not seem to be narrowing (Abstract #0956).

Released: 2-Nov-2021 10:45 AM EDT
Race, Age, Sex and Language Affected Telemedicine Use by Rheumatology Clinic Patients During COVID-19 Pandemic
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows a significant lack of fairness among telemedicine and electronic patient portals used by rheumatology clinic patients based on their race, age, sex and English language proficiency.

Released: 1-Nov-2021 4:55 PM EDT
Patients taking Rituximab Could Benefit from Third COVID-19 Vaccine Dose
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows patients using rituximab were able to produce antibodies against COVID-19 after receiving a third vaccine dose, even if there was no development of the antibody after the first two.

Released: 1-Nov-2021 4:55 PM EDT
Nearly One Third of Lupus Patients in One Study Had Low Responses to COVID-19 Vaccines
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that nearly 30% of patients with lupus in a multi-ethnic and multi-racial study had a low response to the new COVID-19 vaccines.

Released: 1-Nov-2021 4:50 PM EDT
Black People with Systemic Sclerosis May Have More Severe Disease, Worse Prognosis
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that Black people living with systemic sclerosis may have more severe disease and worse prognosis than patients in other racial or ethnic groups.

Released: 1-Nov-2021 4:45 PM EDT
Study Finds Cycling JAK Inhibitors Effective Option for Patients with Difficult-to-Treat RA
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with difficult-to-treat rheumatoid arthritis who do not have success with JAK inhibitor can achieve success either cycling to other JAKi or switching to a biologic drug.

Released: 1-Nov-2021 4:40 PM EDT
Pregnant Women with Takayasu’s Arteritis and Their Babies at High Risk for Serious Complications
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that pregnant women with Takayasu’s arteritis appear to have a high prevalence of serious maternal and fetal adverse outcomes

Released: 1-Nov-2021 3:55 PM EDT
Virtual Exercise Effective for People with Arthritis and Helps Them Stay Socially Connected Too
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that a virtual exercise program can be safe for people with musculoskeletal conditions, improved their health outcomes, and helped them feel more socially connected.

Released: 1-Nov-2021 3:55 PM EDT
Ultra-Low Dose Rituximab Controls Disease Activity for Most RA Patients in New Study
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows the majority of rheumatoid arthritis patients on an ultra-low dose of rituximab maintained low disease activity for up to 4 years, and rarely needed to switch to other biologic drugs.

Released: 1-Nov-2021 3:50 PM EDT
Higher Doses and Longer Use of Hydroxychloroquine Increase Risk of Severe Eye Complication
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be risk factors for retinopathy in people using hydroxychloroquine for rheumatoid arthritis.

Released: 1-Nov-2021 3:45 PM EDT
Groundbreaking Study Reveals Clues to Predict Mortality in Rare VEXAS Syndrome
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows a relationship between genotype, bone marrow failure and survival in patients with the rare autoinflammatory disease VEXAS syndrome, which was only identified in 2020.

Released: 1-Nov-2021 3:40 PM EDT
Hydroxychloroquine, Mainstay Lupus Treatment, Not Associated With Serious Cardiac Complication
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that hydroxychloroquine does not appear to be associated with QTc interval prolongation.

Released: 1-Nov-2021 3:30 PM EDT
Platelet Inhibitors May Reduce Digital Ulcers, a Common, Painful Systemic Sclerosis Complication
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that use of platelet inhibitors could be associated with a reduction in the occurrence of digital ulcers in people with systemic sclerosis.

Released: 1-Nov-2021 3:20 PM EDT
Study Finds COVID-19 Vaccine Not Associated with Severe Disease Flare in Patients with Rheumatic Diseases
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that the COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases.

Released: 1-Nov-2021 3:15 PM EDT
Biologics Now Most Common Treatment for Children with Systemic JIA, and Many Have Excellent Results
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that biologics were the most common initial treatment prescribed to treat systemic juvenile idiopathic arthritis patients in one major registry.

Released: 12-Oct-2021 9:40 AM EDT
ACR Convergence 2021 Early Press Registration Closing October 27
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) is providing complimentary registration to journalists wishing to write about studies presented at ACR Convergence 2021, the ACR’s annual meeting taking place Nov. 1 – 10.

Released: 23-Sep-2021 12:30 PM EDT
Press Registration Now Open for ACR Convergence 2021
American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) is providing complimentary registration to journalists wishing to write about studies presented at ACR Convergence 2021, the ACR’s annual meeting taking place Nov. 1 – 10.

Released: 15-Sep-2021 5:30 PM EDT
American College of Rheumatology Responds to 2022 Medicare Physician Fee Schedule Proposed Rule
American College of Rheumatology (ACR)

In comments submitted to the Centers for Medicare and Medicaid Services (CMS), the American College of Rheumatology (ACR) shared its perspective on the CY 2022 Medicare Physician Fee Schedule and Quality Payment Program proposed rule.

Released: 11-Aug-2021 11:00 AM EDT
ACR Commends CMS Decision to Withdraw Most Favored Nation Model
American College of Rheumatology (ACR)

The American College of Rheumatology applauds the Centers for Medicare and Medicaid Services’ decision to withdraw a proposed rule to implement the “Most Favored Nation” payment model for Part B drugs.

Released: 2-Aug-2021 4:05 PM EDT
Town Hall on Effectiveness of COVID-19 Vaccination in Immunosuppressed Patients Hosted by the American College of Rheumatology
American College of Rheumatology (ACR)

How effective COVID-19 vaccines have been in immunosuppressed and rheumatic disease patients remains an incompletely answered question. The American College of Rheumatology (ACR) has organized an expert panel to share what we are learning from real-world data and answer questions.

Released: 2-Aug-2021 11:25 AM EDT
Award-Winning Journalist and CDC Principal Investigator to Serve as ACR Convergence 2021 Keynote Speaker
American College of Rheumatology (ACR)

Convergence 2021, the annual meeting of the American College of Rheumatology (ACR), returns to a virtual meeting platform Nov. 1 - 10. This year’s meeting will include presentations from over 320 clinicians, researchers and health experts, including this year’s keynote speaker, Dr. Seema Yasmin.

Released: 9-Jul-2021 10:30 AM EDT
The American College of Rheumatology/Vasculitis Foundation Release Three New Guidelines for Treatment of Vasculitis
American College of Rheumatology (ACR)

 The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), released three new guidelines for the treatment and management of systemic vasculitis.

Released: 6-Jul-2021 10:20 AM EDT
ACR Co-Authors Amicus Brief in Support of North Dakota Regulating PBM Industry
American College of Rheumatology (ACR)

The Alliance for Transparent & Affordable Prescriptions (ATAP), the Community Oncology Alliance (COA), and American Pharmacies filed an amicus brief with the 8th Circuit Court of Appeals in support of North Dakota’s efforts to regulate practices of pharmacy benefit managers (PBMs).


Showing results

150 of 679

close
0.38754